184 related articles for article (PubMed ID: 36992730)
1. Effective assay technologies fit for large-scale population screening of type 1 diabetes.
Jia X; Yu L
Front Clin Diabetes Healthc; 2022; 3():1034698. PubMed ID: 36992730
[TBL] [Abstract][Full Text] [Related]
2. High-Throughput Multiplex Electrochemiluminescence Assay Applicable to General Population Screening for Type 1 Diabetes and Celiac Disease.
He L; Jia X; Rasmussen CG; Waugh K; Miao D; Dong F; Frohnert B; Steck AK; Simmons KM; Rewers M; Yu L
Diabetes Technol Ther; 2022 Jul; 24(7):502-509. PubMed ID: 35238620
[No Abstract] [Full Text] [Related]
3. Islet autoantibodies in disease prediction and pathogenesis.
Jia X; Gu Y; High H; Yu L
Diabetol Int; 2020 Jan; 11(1):6-10. PubMed ID: 31949998
[TBL] [Abstract][Full Text] [Related]
4. High-throughput multiplexed autoantibody detection to screen type 1 diabetes and multiple autoimmune diseases simultaneously.
Gu Y; Zhao Z; Waugh K; Miao D; Jia X; Cheng J; Michels A; Rewers M; Yang T; Yu L
EBioMedicine; 2019 Sep; 47():365-372. PubMed ID: 31447394
[TBL] [Abstract][Full Text] [Related]
5. Combined Detection of Islet Autoantibodies for Clinical Diagnosis of Type 1 Diabetes in the Low-Prevalence Population.
Qi Y; Chen S; Chen H; Chen Y; Shi Y; Qin Y; Zhang M; Yang T; Gu Y
J Clin Endocrinol Metab; 2023 May; 108(6):e326-e333. PubMed ID: 36480302
[TBL] [Abstract][Full Text] [Related]
6. A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases.
Jia X; He L; Gu Y; High H; Yu L
J Vis Exp; 2020 May; (159):. PubMed ID: 32538917
[TBL] [Abstract][Full Text] [Related]
7. A multiplex assay combining insulin, GAD, IA-2 and transglutaminase autoantibodies to facilitate screening for pre-type 1 diabetes and celiac disease.
Zhao Z; Miao D; Michels A; Steck A; Dong F; Rewers M; Yu L
J Immunol Methods; 2016 Mar; 430():28-32. PubMed ID: 26809048
[TBL] [Abstract][Full Text] [Related]
8. T1D Autoantibodies: room for improvement?
Yu L; Zhao Z; Steck AK
Curr Opin Endocrinol Diabetes Obes; 2017 Aug; 24(4):285-291. PubMed ID: 28509692
[TBL] [Abstract][Full Text] [Related]
9. A High-throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19.
Jia X; He L; Miao D; Zhang C; Rewers M; Yu L
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35876559
[TBL] [Abstract][Full Text] [Related]
10. High-affinity ZnT8 Autoantibodies by Electrochemiluminescence Assay Improve Risk Prediction for Type 1 Diabetes.
Jia X; He L; Miao D; Waugh K; Rasmussen CG; Dong F; Steck AK; Rewers M; Yu L
J Clin Endocrinol Metab; 2021 Nov; 106(12):3455-3463. PubMed ID: 34343303
[TBL] [Abstract][Full Text] [Related]
11. Establishing reference intervals for islet autoantibodies in Han Chinese type 1 diabetes.
Fu Y; Zhang C; Gu Y; Ge S; Li J; Feng J; Zhang L; Liu W; Chen H
Scand J Clin Lab Invest; 2021 Dec; 81(8):641-648. PubMed ID: 34779329
[TBL] [Abstract][Full Text] [Related]
12. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
13. General population screening for type 1 diabetes using islet autoantibodies at the preschool vaccination visit: a proof-of-concept study (the T1Early study).
Scudder C; Townson J; Bowen-Morris J; Gillespie K; Evans P; Jones S; Thomas NPB; Stanford J; Fox R; Todd JA; Greenfield S; Dayan CM; Besser REJ
Arch Dis Child; 2024 Jun; ():. PubMed ID: 38925883
[TBL] [Abstract][Full Text] [Related]
14. Understanding Islet Autoantibodies in Prediction of Type 1 Diabetes.
Jia X; Yu L
J Endocr Soc; 2023 Dec; 8(1):bvad160. PubMed ID: 38169963
[TBL] [Abstract][Full Text] [Related]
15. "Life or death": Experiences of insulin insecurity among adults with type 1 diabetes in the United States.
Willner S; Whittemore R; Keene D
SSM Popul Health; 2020 Aug; 11():100624. PubMed ID: 32676533
[TBL] [Abstract][Full Text] [Related]
16. Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children.
Ng K; Anand V; Stavropoulos H; Veijola R; Toppari J; Maziarz M; Lundgren M; Waugh K; Frohnert BI; Martin F; Lou O; Hagopian W; Achenbach P;
Diabetologia; 2023 Jan; 66(1):93-104. PubMed ID: 36195673
[TBL] [Abstract][Full Text] [Related]
17. Large-Scale Screening in General Population Children for Celiac Disease with a Multiplex Electrochemiluminescence (ECL) Assay.
He L; Jia X; Gu Y; Miao D; Waugh K; Geno C; Liu E; Rewers M; Yu L
J Immunol Res; 2020; 2020():8897656. PubMed ID: 33426098
[TBL] [Abstract][Full Text] [Related]
18. Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes.
Gu Y; Jia X; Vartak T; Miao D; Dong F; Jerram ST; Rewers M; Ferrara A; Lawrence JM; Yu L; Leslie RD;
Diabetologia; 2021 Sep; 64(9):2052-2060. PubMed ID: 34272582
[TBL] [Abstract][Full Text] [Related]
19. Novel autoantibodies to the Ī²-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes.
Gu Y; Merriman C; Guo Z; Jia X; Wenzlau J; Li H; Li H; Rewers M; Yu L; Fu D
J Autoimmun; 2021 Aug; 122():102677. PubMed ID: 34130115
[TBL] [Abstract][Full Text] [Related]
20. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
